{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:13:32Z","timestamp":1793888012036,"version":"4.8.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,11]],"date-time":"2027-03-11T00:00:00Z","timestamp":1804723200000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-GM140851"],"award-info":[{"award-number":["R35-GM140851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.molmed.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:13:42Z","timestamp":1757517222000},"page":"284-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["MAFLD: a ferroptotic disease"],"prefix":"10.1016","volume":"32","author":[{"given":"Shaojie","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3179-4777","authenticated-orcid":false,"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2025.08.006_bb0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2025.08.006_bb0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41575-024-00938-9","article-title":"Envisioning how to advance the MASH field","volume":"21","author":"Allen","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0020","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","article-title":"Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases","volume":"83","author":"Cui","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0025","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1016\/j.molcel.2024.11.001","article-title":"5H7c: a rabbit monoclonal antibody detecting ferroptotic cells","volume":"84","author":"Cui","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","article-title":"The coming decade of cell death research: five riddles","volume":"177","author":"Green","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Conrad","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2025.08.006_bb0060","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101470","article-title":"Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity","volume":"298","author":"Valentine","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107189119","article-title":"FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids","volume":"119","author":"Cui","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.08.006_bb0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/ars.2023.0237","article-title":"LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity","volume":"39","author":"Cui","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molmed.2025.08.006_bb0090","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.chembiol.2022.06.004","article-title":"Context-dependent regulation of ferroptosis sensitivity","volume":"29","author":"Magtanong","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0095","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","article-title":"Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state","volume":"26","author":"Magtanong","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0100","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chembiol.2023.10.012","article-title":"Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury","volume":"31","author":"Mann","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","article-title":"Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration","volume":"9","author":"Carlson","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","article-title":"Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death","volume":"567","author":"Garcia-Bermudez","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.molcel.2024.03.003","article-title":"7-Dehydrocholesterol: a sterol shield against an iron sword","volume":"84","author":"Cui","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0150","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2025.08.006_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","article-title":"Achieving life through death: redox biology of lipid peroxidation in ferroptosis","volume":"27","author":"Bay\u0131r","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molmed.2025.08.006_bb0165","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2025.08.006_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.molmed.2025.08.006_bb0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/antiox12020408","article-title":"Mitochondrial peroxiredoxin 3 is rapidly oxidized and hyperoxidized by fatty acid hydroperoxides","volume":"12","author":"Cardozo","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.molmed.2025.08.006_bb0180","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease \u2013 a starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.molmed.2025.08.006_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.freeradbiomed.2018.11.036","article-title":"Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite \u03b1-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects","volume":"131","author":"Torquato","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molmed.2025.08.006_bb0190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s43587-024-00652-w","article-title":"Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress","volume":"4","author":"Du","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.molmed.2025.08.006_bb0195","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0200","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3390\/nu11122941","article-title":"The secrets of the Mediterranean diet. Does [only] olive oil matter?","volume":"11","author":"Mazzocchi","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.molmed.2025.08.006_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.redox.2016.10.006","article-title":"Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation","volume":"10","author":"Kitsati","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0210","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ijms19030686","article-title":"Potential health benefits of olive oil and plant polyphenols","volume":"19","author":"Gorzynik-Debicka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.08.006_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","article-title":"Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease","volume":"52","author":"Leamy","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molmed.2025.08.006_bb0220","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/s41418-021-00769-0","article-title":"Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis","volume":"28","author":"Cui","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2025.08.006_bb0225","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1021\/acs.analchem.0c01933","article-title":"Unequivocal mapping of molecular ether lipid species by LC\u2013MS\/MS in plasmalogen-deficient mice","volume":"92","author":"Koch","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0230","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1073\/pnas.111138698","article-title":"Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR","volume":"98","author":"Ou","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.08.006_bb0235","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1074\/jbc.M007273200","article-title":"Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 Cells","volume":"276","author":"Hannah","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","article-title":"Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice","volume":"50","author":"Moon","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2025.08.006_bb0245","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.08.006_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-nutr-061021-030223","article-title":"Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use","volume":"43","author":"Spooner","year":"2023","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.molmed.2025.08.006_bb0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-ecosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a Phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2025.08.006_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCG.0000000000000099","article-title":"Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis","volume":"49","author":"Dasarathy","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0265","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis","volume":"187","author":"Qiu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0270","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.14309\/ajg.0000000000001229","article-title":"Red meat consumption and risk of nonalcoholic fatty liver disease in a population with low meat consumption: the Golestan Cohort Study","volume":"116","author":"Hashemian","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0275","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/FJC.0000000000001328","article-title":"Ethoxyquin is a competent radical-trapping antioxidant for preventing ferroptosis in doxorubicin cardiotoxicity","volume":"80","author":"Tadokoro","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0280","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.molmed.2025.08.006_bb0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0304-4165(74)90091-9","article-title":"Biochemical studies on the mechanism of action of liver poisons III. Depletion of liver glutathione in ethionine poisoning","volume":"372","author":"Glaser","year":"1974","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.molmed.2025.08.006_bb0290","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2025.08.006_bb0295","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0300","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0305","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2025.08.006_bb0310","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0315","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2025.08.006_bb0320","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.23812","article-title":"Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2025.08.006_bb0325","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jhep.2024.10.048","article-title":"PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis","volume":"82","author":"Wang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0330","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","article-title":"PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein","volume":"15","author":"Johnson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2025.08.006_bb0335","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2025.08.006_bb0340","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1073\/pnas.1901974116","article-title":"Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis","volume":"116","author":"BasuRay","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.08.006_bb0345","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1074\/jbc.RA118.002333","article-title":"Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets","volume":"293","author":"Mitsche","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41467-023-44412-7","article-title":"Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2025.08.006_bb0355","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","article-title":"Antioxidant role for lipid droplets in a stem cell niche of drosophila","volume":"163","author":"Bailey","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2025.08.006_bb0360","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1038\/s41467-022-31963-4","article-title":"Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer","volume":"13","author":"Bartolacci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2025.08.006_bb0365","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2025.08.006_bb0370","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","author":"Smagris","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2025.08.006_bb0375","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcmgh.2021.12.008","article-title":"Hepatic TM6SF2 Is required for lipidation of VLDL in a pre-Golgi compartment in mice and rats","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0380","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2025.08.006_bb0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCRESAHA.123.323284","article-title":"VLDL biogenesis and secretion: it takes a village","volume":"134","author":"van Zwol","year":"2024","journal-title":"Circ. Res."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425001947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425001947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:43:38Z","timestamp":1773254618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491425001947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1471491425001947"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2025.08.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAFLD: a ferroptotic disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}